Mar 3, 2026 08:31AM
Mar 3, 2026 08:30AM
Nov 10, 2025 04:10PM
Nov 10, 2025 04:05PM
Oct 27, 2025 06:00AM
Aug 25, 2025 06:00AM
Aug 25, 2025 06:00AM Theravance Biopharma Completes Enrollment in Pivotal Phase 3 CYPRESS Study of Ampreloxetine in Patients with Symptomatic Neurogenic Orthostatic Hypotension due to Multiple System Atrophy
Aug 12, 2025 04:08PM
Aug 12, 2025 04:05PM
Jul 28, 2025 06:00AM
May 8, 2025 04:34PM
May 8, 2025 04:05PM
Apr 24, 2025 06:00AM
Feb 26, 2025 04:34PM Theravance Biopharma (TBPH) Misses Q4 EPS by 11c ; Provides Outlook
Feb 26, 2025 04:05PM
Feb 12, 2025 06:00AM
Nov 12, 2024 04:11PM
Nov 12, 2024 04:05PM
Oct 24, 2024 06:00AM
Aug 6, 2024 06:39AM
Aug 5, 2024 04:14PM Theravance Biopharma (TBPH) Misses Q2 EPS by 13c, provides guidance
Aug 5, 2024 04:05PM
Jul 22, 2024 06:00AM
May 13, 2024 04:07PM
May 13, 2024 04:05PM
Apr 29, 2024 06:00AM
Feb 26, 2024 04:17PM
Feb 26, 2024 04:05PM Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
Feb 14, 2024 06:00AM
Nov 7, 2023 04:32PM
Nov 7, 2023 04:28PM
Oct 19, 2023 06:00AM
Aug 7, 2023 04:17PM
Aug 7, 2023 04:05PM
Jul 24, 2023 06:00AM Theravance Biopharma to Report Second Quarter 2023 Financial Results on August 7, 2023
May 8, 2023 04:28PM
May 8, 2023 04:05PM
Apr 24, 2023 06:00AM
Feb 27, 2023 04:25PM
Feb 27, 2023 04:05PM
Feb 27, 2023 09:01AM
Feb 27, 2023 09:00AM Irenic Sends Letter to Theravance Biopharma Regarding the Urgent Need for a Governance Overhaul, Capital Return and Strategic Review
Feb 21, 2023 06:00AM
Nov 7, 2022 04:05PM
Oct 31, 2022 06:00AM
Aug 4, 2022 04:56PM
Aug 4, 2022 04:05PM
Jul 28, 2022 06:00AM
Jul 13, 2022 04:18PM Theravance Biopharma (TBPH) to Sell TRELEGY ELLIPTA Royalty Interests to Royalty Pharma (RPRX) for Approximately $1.1 Billion in Upfront Cash with Over $1.5 Billion in Potential Total Value
Jul 13, 2022 04:17PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All